Dr. Yogish Kudva, MD
Claim this profileMayo Clinic
Studies Diabetes Mellitus
Studies Diabetic Retinopathy
7 reported clinical trials
14 drugs studied
Affiliated Hospitals
Clinical Trials Yogish Kudva, MD is currently running
Hybrid Closed Loop System
for Type 1 Diabetes
The purpose of this study is to evaluate the safety and effectiveness of the Hybrid Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with type 1 diabetes will be studied. The study population will have a large range for duration of diabetes and glycemic control, as measured by glycosylated hemoglobin (A1C). They will be enrolled in the study regardless of their prior diabetes regimen, including using Multiple Daily Injections (MDI), Continuous Subcutaneous Insulin Infusion (CSII) or Sensor-Augmented Pump therapy (SAP)
Recruiting1 award N/A17 criteria
Pioglitazone vs Empagliflozin
for Diabetes
The purpose of this study is to evaluate efficacy of pioglitazone (PIO) versus empagliflozin (EMPA) to improve glycemic control in people with Chronic Pancreatitis (CP) or Recurrent Acute Pancreatitis (RAP) associated with Diabetes Mellitus (DM). To evaluate mixed meal response in PIO versus EMPA group to better understand physiology of both therapies in CP-DM.
Recruiting1 award Phase 22 criteria
More about Yogish Kudva, MD
Clinical Trial Related7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Yogish Kudva, MD has experience with
- Empagliflozin
- Pioglitazone
- PACTAID App
- 670G And 770G Insulin Pump
- Subject's Current Diabetes Therapy
- Lyumjev® Lispro-aabc
Breakdown of trials Yogish Kudva, MD has run
Diabetes Mellitus
Diabetic Retinopathy
Type 1 Diabetes
Chronic Pancreatitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yogish Kudva, MD specialize in?
Yogish Kudva, MD focuses on Diabetes Mellitus and Diabetic Retinopathy. In particular, much of their work with Diabetes Mellitus has involved treating patients, or patients who are undergoing treatment.
Is Yogish Kudva, MD currently recruiting for clinical trials?
Yes, Yogish Kudva, MD is currently recruiting for 3 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Yogish Kudva, MD has studied deeply?
Yes, Yogish Kudva, MD has studied treatments such as Empagliflozin, Pioglitazone, PACTAID App.
What is the best way to schedule an appointment with Yogish Kudva, MD?
Apply for one of the trials that Yogish Kudva, MD is conducting.
What is the office address of Yogish Kudva, MD?
The office of Yogish Kudva, MD is located at: Mayo Clinic, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.